BioNTech Stock Pops On Massive Earnings Beat; Company Looks Beyond Covid

Investors2021-08-09

BioNTech stock popped on Monday after the Covid vaccine maker reported adjusted profit of $12.67 per share on $6.24 billion in second-quarter sales.

Analysts polled by FactSet expected BioNTech to earn $8.87 per share on $3.83 billion in sales.

In the year-earlier period, BioNTech lost 45 cents per share and reported $49 million in revenue.

BioNTech didn't offer full-year sales and earnings guidance. The company noted it has agreements in place to deliver 2.2 billion doses of its Covid vaccine in 2021, and is now working on multiple cancer drugs. Analysts called for the Pfizer partner to earn $33.12 a share on $14.68 billion in sales.

In premarket trading on today's stock market, BioNTech stock jumped 5% near 408.50. Shares have a perfect Relative Strength Rating of 99, according to IBD Digital. This puts BioNTech stock in the top 1% of all companies in terms of 12-month performance.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • Ktzy321
    2021-08-10
    Ktzy321
    When is this pandemic ending 
  • BlueDragon
    2021-08-10
    BlueDragon
    Sure huge revenues and  profits, with the world at their mercy.
  • Vomous
    2021-08-10
    Vomous
    To the moon
  • Andrew210782
    2021-08-10
    Andrew210782
    Like
  • NicElo
    2021-08-09
    NicElo
    Up
  • Redfox24
    2021-08-09
    Redfox24
    Upup
发表看法
26